Two people in Denmark suffered from brain hemorrhages after receiving AstraZeneca’s COVID-19 vaccine, according to multiple reports.
Two hospital staff received the vaccine less than 14 days before suffering brain hemorrhages, Reuters reported. The Danish Medicines Agency confirmed that it had received two “serious reports”, but did not give further details.
Le New York Times reported that one of the patients has died and the other, a woman in her 30s, is critically ill.
The Hill has reached out to AstraZeneca for comment.
The reports are the latest in a series of media reports of a small number of people suffering from blood clots following injections of the AstraZeneca vaccine. The news also represents the second death in Denmark after the administration of the Anglo-Swedish company vaccine.
Denmark stopped use of the vaccine on March 11 after a 60-year-old woman died of a blood clot following the injection. Other countries, including Germany, France, Italy, Spain, Ireland and Norway, have also blocked its use.
The vaccine has not yet been cleared by the United States Food and Drug Administration.
AstraZeneca said last sunday that there was no evidence linking the vaccine to blood clots after examining 17 million shots administered across Europe.
The European Medicines Agency, the European Union’s medicines regulator, said Thursday that AstraZeneca vaccine is safe and effective to use, but has not ruled out a link to blood clots. The agency said it would add a warning to the product about the possibility of the side effect.
Reuters noted that some countries reversed their decisions when the EMA was announced.
The World Health Organization has advised that countries continue to use the vaccine, claiming that the benefits of the vaccine outweigh its risks.